Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Should thyroid-stimulating hormone goals be reviewed in patients with type 1 diabetes mellitus? Results from the Brazilian Type 1 Diabetes Study Group.

Rodacki M, Zajdenverg L, Dantas JR, de Oliveira JE, Luiz RR, Cobas RA, Palma CC, Negrato CA, Gomes MB.

Diabet Med. 2014 Dec;31(12):1665-72. doi: 10.1111/dme.12530. Epub 2014 Jul 25.

PMID:
24961827
3.

The temporal development of retinopathy and nephropathy in type 1 diabetes mellitus during 15 years diabetes duration.

Lövestam-Adrian M, Agardh E, Agardh CD.

Diabetes Res Clin Pract. 1999 Aug;45(1):15-23.

PMID:
10499881
4.

[Thyroid hormone changes in women with pre-eclampsia and its relationship with the presence of pre-eclampsia].

Zhou J, Du J, Ma B, Liu X, Qiu H, Li J, Wang X.

Zhonghua Fu Chan Ke Za Zhi. 2014 Feb;49(2):109-13. Chinese.

PMID:
24739642
5.

Spectrum of subclinical and overt hypothyroidism: effect on thyrotropin, prolactin, and thyroid reserve, and metabolic impact on peripheral target tissues.

Staub JJ, Althaus BU, Engler H, Ryff AS, Trabucco P, Marquardt K, Burckhardt D, Girard J, Weintraub BD.

Am J Med. 1992 Jun;92(6):631-42.

PMID:
1605145
6.

Association Between HbA1c Variability and Risk of Microvascular Complications in Adolescents With Type 1 Diabetes.

Virk SA, Donaghue KC, Cho YH, Benitez-Aguirre P, Hing S, Pryke A, Chan A, Craig ME.

J Clin Endocrinol Metab. 2016 Sep;101(9):3257-63. doi: 10.1210/jc.2015-3604. Epub 2016 May 17.

PMID:
27186858
7.

Association of thyroid function with estimated glomerular filtration rate in a population-based study: the HUNT study.

Asvold BO, Bjøro T, Vatten LJ.

Eur J Endocrinol. 2011 Jan;164(1):101-5. doi: 10.1530/EJE-10-0705. Epub 2010 Oct 7. Erratum in: Eur J Endocrinol. 2011 Feb;164(2):316.

8.
9.

Plasma Homocysteine is Associated with Retinopathy in Type 1 Diabetic Patients in the Absence of Nephropathy.

Bulum T, Blaslov K, Duvnjak L.

Semin Ophthalmol. 2016;31(3):198-202. doi: 10.3109/08820538.2014.912338. Epub 2014 May 2.

PMID:
24785685
10.

Renal and retinal microangiopathy after 15 years of follow-up study in a sample of Type 1 diabetes mellitus patients.

Romero P, Salvat M, Fernández J, Baget M, Martinez I.

J Diabetes Complications. 2007 Mar-Apr;21(2):93-100.

PMID:
17331857
11.

Thyroid hormone replacement and growth of children with subclinical hypothyroidism and diabetes.

Chase HP, Garg SK, Cockerham RS, Wilcox WD, Walravens PA.

Diabet Med. 1990 May;7(4):299-303.

PMID:
2140081
12.

Retinopathy in diabetic patients aged 15-50 years in the county of Umeå, Sweden.

Larsson LI, Alm A, Bergenheim T, Lithner F, Bergström R.

Acta Ophthalmol Scand. 1999 Aug;77(4):430-6.

13.

Association of Thyroid-Stimulating Hormone Levels with Microvascular Complications in Type 2 Diabetes Patients.

Qi Q, Zhang QM, Li CJ, Dong RN, Li JJ, Shi JY, Yu DM, Zhang JY.

Med Sci Monit. 2017 Jun 4;23:2715-2720.

14.

Metabolic control and prevalence of microvascular complications in young Danish patients with Type 1 diabetes mellitus. Danish Study Group of Diabetes in Childhood.

Olsen BS, Johannesen J, Sjølie AK, Borch-Johnsen K, Hougarrdss P, Thorsteinsson B, Prammingss S, Marinelli K, Mortensen HB.

Diabet Med. 1999 Jan;16(1):79-85.

PMID:
10229298
15.

Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring.

Vos FE, Schollum JB, Coulter CV, Manning PJ, Duffull SB, Walker RJ.

Nephrology (Carlton). 2012 Feb;17(2):182-8. doi: 10.1111/j.1440-1797.2011.01517.x.

PMID:
21883672
16.

A multi-year analysis of islet transplantation compared with intensive medical therapy on progression of complications in type 1 diabetes.

Warnock GL, Thompson DM, Meloche RM, Shapiro RJ, Ao Z, Keown P, Johnson JD, Verchere CB, Partovi N, Begg IS, Fung M, Kozak SE, Tong SO, Alghofaili KM, Harris C.

Transplantation. 2008 Dec 27;86(12):1762-6. doi: 10.1097/TP.0b013e318190b052.

PMID:
19104418
17.

Evidence of a threshold value of glycated hemoglobin to improve the course of renal function in type 2 diabetes with typical diabetic glomerulopathy.

Brocco E, Velussi M, Cernigoi AM, Abaterusso C, Bruseghin M, Carraro A, Sambataro M, Piarulli F, Sfriso A, Nosadini R.

J Nephrol. 2001 Nov-Dec;14(6):461-71.

PMID:
11783602
18.

Skin autofluorescence is associated with severity of vascular complications in Japanese patients with Type 2 diabetes.

Tanaka K, Tani Y, Asai J, Nemoto F, Kusano Y, Suzuki H, Hayashi Y, Asahi K, Nakayama M, Miyata T, Watanabe T.

Diabet Med. 2012 Apr;29(4):492-500. doi: 10.1111/j.1464-5491.2011.03448.x.

PMID:
21916970
19.

Type 1 diabetes in pre-school children--long-term metabolic control, associated autoimmunity and complications.

Levy-Shraga Y, Lerner-Geva L, Boyko V, Graph-Barel C, Mazor-Aronovitch K, Modan-Moses D, Pinhas-Hamiel O.

Diabet Med. 2012 Oct;29(10):1291-6. doi: 10.1111/j.1464-5491.2012.03682.x.

PMID:
22507070
20.

Association between subclinical hypothyroidism and severe diabetic retinopathy in Korean patients with type 2 diabetes.

Kim BY, Kim CH, Jung CH, Mok JO, Suh KI, Kang SK.

Endocr J. 2011;58(12):1065-70. Epub 2011 Sep 17.

Supplemental Content

Support Center